Impact Factor
3.28
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.24
507 total citations
h5-index
28
h5 depth signal
Cited share
73.5%
172 of 234
Total citations
507
Citation footprint
Metric signal
2.41
External metric anchor
Self-citation
8.3%
42 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
1,236
China
114
Turkey
98
United States
95
South Korea
30
Citing Fields of Research
Musculoskeletal Disorders
1,107
Auto-Inflammatory Disorders
532
Immunology
132
Osteopathies
80
Hematology
65
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
3,685
Articles tracked across the journal lifetime
Indexed publication set
234
172 cited publications
Last 12 months
128
10.7 publications/month
Open access share
43.8%
56 OA publications in the last year
Leading citing country
Japan
1,236 citing publications
Leading citing field
Musculoskeletal Disorders
1,107 citing publications
Latest tracked publication
17 October 2026
10 recent records available
Coverage & Indexing History
v16n1, 2006-
v16n1, 2006-
Research Focus & Classification
Indexed Subjects
Musculoskeletal Disorders
Auto-Inflammatory Disorders
Issuing & Sponsoring Bodies
Contributor
Nihon Ryūmachi Gakkai
Broad Categories
Rheumatology
Musculoskeletal Disorders
Auto-Inflammatory Disorders
MeSH Descriptors
Collagen Diseases
Rheumatic Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1093/mr/roag089
Open DOI
Treatment persistence and clinical outcomes following subcutaneous methotrexate initiation in patients with rheumatoid arthritis: a real-world observational study
Objectives: This study aimed to evaluate treatment persistence and safety following subcutaneous methotrexate (MTX) initiation in Japanese patients with RA and to assess clinical outcomes among patients who directly switched from oral to...
02
DOI 10.1093/mr/roag086
Open DOI
Triggering Factors in Pediatric Familial Mediterranean Fever: A New Perspective on Colchicine Resistance
Objectives: In our study, we aimed to determine the frequency of attack-triggering factors in pediatric patients with colchicine-resistant familial Mediterranean fever (FMF), to examine their relationship with genotype, and to evaluate c...
03
DOI 10.1093/mr/roag087
Open DOI
Human T-Cell Leukaemia Virus Type 1-Associated Myelopathy in Patients with Rheumatoid Arthritis: A Case Series Highlighting Functional Disability and Diagnostic Challenges
Objectives: Although rheumatoid arthritis (RA) and human T-cell leukaemia virus type 1 (HTLV-1)–associated myelopathy/tropical spastic paraparesis (HAM/TSP) occasionally coexist, their clinical characteristics and impact on patient outco...
04
DOI 10.1093/mr/roag088
Open DOI
Clinical characteristics associated with pulmonary function decline despite sustained nintedanib therapy in systemic autoimmune rheumatic disease–related progressive pulmonary fibrosis
Objective: To identify clinical factors associated with pulmonary function decline despite sustained nintedanib treatment for ≥1 year in patients with systemic autoimmune rheumatic disease-associated interstitial lung disease (SARD-ILD) ...
05
DOI 10.1093/mr/roag085
Open DOI
Revisiting liver monitoring during methotrexate therapy in rheumatoid arthritis: Implications of HBV reactivation, MASLD, and non-invasive fibrosis assessment
Liver function monitoring remains a cornerstone of safety surveillance during methotrexate (MTX) therapy for rheumatoid arthritis. Traditionally, monitoring has focused on hepatitis B virus (HBV) reactivation and chronic MTX hepatotoxici...
06
DOI 10.1093/mr/roag082
Open DOI
The association between cardiac arrhythmia and autoantibodies in systemic sclerosis
Objectives: This study aims to investigate the association between specific autoantibodies and cardiac arrhythmias in Japanese patients with systemic sclerosis (SSc). Methods: Arrhythmias in patients with SSc treated at Kyoto University ...
07
08
DOI 10.1093/mr/roag076
Open DOI
Early detection, treatment initiation, and long-term health outcomes in patients with connective tissue disease-associated pulmonary arterial hypertension: A systematic literature review and expert consensus
Objective: This study aimed to explore evidence related to long-term health outcomes for patients with connective tissue disease (CTD)-associated pulmonary arterial hypertension (PAH) and any clinical practices associated with screening,...
09
DOI 10.1093/mr/roag080
Open DOI
Methotrexate and malignancy in rheumatoid arthritis: Evidence, risks, and clinical considerations
In this review, we summarized the current evidence on the risks of incident malignancy and cancer recurrence in patients with rheumatoid arthritis (RA) treated with methotrexate (MTX). Before considering the effect of MTX, it is importan...
10
DOI 10.1093/mr/roag075
Open DOI
Clinical characteristics of enthesitis-related arthritis and outcomes of treatment with salazosulfapyridine
Objectives: Enthesitis-related arthritis (ERA), characterized by chronic arthritis and/or enthesitis, is a relatively rare subtype of juvenile idiopathic arthritis. Achieving sustained disease control can be challenging. We aimed to char...
Bibliographical & Catalog Notes
Title from cover.
Latest issue consulted: Vol. 10, no. 2 (2000).
Also issued online.
v. 1, no. 1 (Mar. 2000)20060329 Notice not published Printed on acid-free paper